SCHEMBL10044369

SCHEMBL10044369

CNC(=O)CCCCNCCCOC

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.56
ALDH1A1 P00352 5/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
HPGD P15428 1/20 0.42
KDM4E B2RXH2 11/20 0.40
LMNA P02545 3/20 0.40
GAA P10253 2/20 0.40
NPC1 O15118 1/20 0.40
RECQL P46063 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
PAOX Q6QHF9 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
USP2 O75604 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20176413 0.93 TSHR (0.47) TSHRALDH1A1KMT2AMEN1HPGD
SCHEMBL12847866 0.91 TSHR (0.53) TSHRALDH1A1KMT2AMEN1HPGD
SCHEMBL27250223 0.89 TSHR (0.47) TSHRALDH1A1KMT2AMEN1HPGD
SCHEMBL22336916 0.87 TSHR (0.48) TSHRALDH1A1KMT2AMEN1HPGD
SCHEMBL211904 0.86 ALDH1A1 (0.56) TSHRALDH1A1KMT2AMEN1HPGD
SCHEMBL22224173 0.84 ALDH1A1 (0.59) TSHRALDH1A1KMT2AMEN1HPGD
SCHEMBL16622315 0.84 ALDH1A1 (0.59) TSHRALDH1A1KMT2AMEN1HPGD
SCHEMBL20231393 0.84 ALDH1A1 (0.59) TSHRALDH1A1KMT2AMEN1HPGD
SCHEMBL7996837 0.84 ALDH1A1 (0.59) TSHRALDH1A1KMT2AMEN1HPGD
SCHEMBL1559633 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420400-B2 System and method for authenticating tablets APDN (B.V.I.), Inc. (US) 2013-04-16 US disclosed
US-8415165-B2 System and method for authenticating sports identification goods APDN (B.V.I.), Inc. (US) 2013-04-09 US disclosed
US-8124333-B2 Methods for covalent linking of optical reporters APDN, Inc. (VG) 2012-02-28 US disclosed
US-20090075261-A1 SYSTEM AND METHOD FOR AUTHENTICATING TABLETS APDN (B.V.I.) INC. (VG) 2009-03-19 US disclosed
US-20090042191-A1 SYSTEM AND METHOD FOR SECURE DOCUMENT PRINTING AND DETECTION APDN (B.V.I.) INC. 2009-02-12 US disclosed
US-20080312427-A1 METHODS FOR COVALENT LINKING OF OPTICAL REPORTERS APDN (B.V.I.) INC. 2008-12-18 US disclosed
US-20080299559-A1 METHODS FOR AUTHENTICATING ARTICLES WITH OPTICAL REPORTERS APDN (B.V.I.) INC. 2008-12-04 US disclosed
US-20080293052-A1 SYSTEM AND METHOD FOR AUTHENTICATING SPORTS IDENTIFICATION GOODS APDN (B.V.I.) INC. 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312427-A1 METHODS FOR COVALENT LINKING OF OPTICAL REPORTERS PCNA, POLL, LIG3 TSHR 3495/4885ALDH1A1 1965/4885KMT2A 2944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.